CN1520857A - Diabetes treating bitter gourd traditional Chinese medicine - Google Patents

Diabetes treating bitter gourd traditional Chinese medicine Download PDF

Info

Publication number
CN1520857A
CN1520857A CNA031117678A CN03111767A CN1520857A CN 1520857 A CN1520857 A CN 1520857A CN A031117678 A CNA031117678 A CN A031117678A CN 03111767 A CN03111767 A CN 03111767A CN 1520857 A CN1520857 A CN 1520857A
Authority
CN
China
Prior art keywords
chinese medicine
fructus momordicae
momordicae charantiae
treatment
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA031117678A
Other languages
Chinese (zh)
Inventor
永 张
张永
王美岭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA031117678A priority Critical patent/CN1520857A/en
Publication of CN1520857A publication Critical patent/CN1520857A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The diabetes treating Chinese medicine balsam pear preparation consists of balsam pear extractive as active component in 1-80 portions and matrix in 20-80 portions. The Chinese medicine is prepared through crushing balsam pear extractive, mixing with matrix and processing into the required form tablet or dripping pill. The matrix for the tablet includes mannitol, chitinamine and sweeter; and that for pilling pill is polyglycol 4000-6000, sodium stearate, glycerine-glutin, urea-citric acid or glyceryl stearate. The Chinese medicine may be well absorbed to treat various diabetes effectively.

Description

A kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Affiliated technical field
The present invention relates to a kind of medicine for the treatment of diabetes, particularly a kind of is the Chinese medicine preparation of main effective ingredient by Fructus Momordicae charantiae extract.
Technical background
Fructus Momordicae charantiae extract is the active drug of treatment diabetes.The health product of being made by Fructus Momordicae charantiae extract are arranged at present, by the Chinese medicine preparation of Fructus Momordicae charantiae extract manufacturing yet there are no in report.
Summary of the invention
At the shortcoming that above-mentioned prior art exists, the object of the present invention is to provide a kind of absorption better, the onset of treatment diabetes is the Fructus Momordicae charantiae Chinese medicine preparation faster.
Technical scheme of the present invention is based on understanding and the Therapeutic Principle of Chinese medicine to onset diabetes mechanism, the invention of tracking modern pharmacological research, the Fructus Momordicae charantiae extract that filters out from plant class Chinese herbal medicine the treatment diabetes is equipped with substrate, buccal tablet and two kinds of Chinese medicine preparation of drop pill of making, the dosage form of this medicine is for being beneficial to absorption especially, and directly absorbs through the oral cavity without stomach.The pharmacological action of Fructus Momordicae charantiae extract is as follows: promote the secretion of serum insulin 1.; 2. the secretion of glucagon suppression; 3. repairing islet cells; 4. blood fat reducing.
The Fructus Momordicae charantiae Chinese medicine preparation of this kind treatment diabetes is made up of medicine and substrate, it is characterized in that (weight portion):
Medicine is Fructus Momordicae charantiae extract 1-80 part;
Substrate 20-80 part;
By the prescription thing of getting it filled, after the pulverizing,, be processed into dosage form with the substrate mixing.Two kinds of dosage forms of buccal tablet and drop pill are arranged.
When described dosage form was drop pill, Fructus Momordicae charantiae extract was preferably 1-40 part; Substrate is Macrogol 4000-6000 or sodium stearate or glycerol-gelatin or carbamide-poly-rafter acid or glyceryl stearate.The preparation method of its drop pill is: after getting Fructus Momordicae charantiae extract and be crushed to 80-100 order granularity by prescription, with the substrate mixing, be heated to 80-100 ℃ of said medicine and enter molten condition, stir, adopting craft or machinery that spice is splashed in 15 ℃ of its liquid paraffins through the rustless steel nib under the 60-80 ℃ of keeping warm mode, cooling forming at room temperature, the demoulding promptly after the shaping.The heavy 1-30mg of drop pill.Day obeys 3 times, each 10.
When described dosage form was tablet, Fructus Momordicae charantiae extract was 1-80 part; Substrate is mannitol: chitosan: sweeting agent corresponds to 1: 0.25~and 0.125: 0.025~0.062.The preparation method of its tablet is: after getting Fructus Momordicae charantiae extract and be crushed to 80-100 order granularity by prescription, with substrate mixing, tabletting.The heavy 800mg of sheet, day is sucked clothes 3 times, each 1-2 sheet.
This medicine has better curative effect to the treatment diabetes.This medicine dropped into clinical trial in 2000, according to 618 routine patients' case history statistics, total effective rate reaches 80%, and this medicine of the common reflection of patient has easy absorption, instant effect, characteristics evident in efficacy.Now show with following case:
Liu XX, the woman, 48 years old, bran urine was sick, and fasting glucose 16mmol/L took this medicine after 1 month, and fasting glucose is reduced to 6.1mmol/L, and the back of taking medicine does not have other discomforts.
Song XX, the man, 50 years old, bran urine was sick, and fasting glucose 14mmol/L took this medicine after 1 month, and cavity blood bran is reduced to 5.6mmol/L, and the back of taking medicine does not have other discomforts.
High XX, the man, 46 years old, bran urine was sick, and fasting glucose 13mmol/L took this medicine after 1 month, and fasting glucose is reduced to 5.1mmol/L, and the back of taking medicine does not have other discomforts.
Specific embodiment:
1, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 40 parts of medicine Fructus Momordicae charantiae extracts; 80 parts of substrate.Substrate is Macrogol 4000-6000
Or sodium stearate or glycerol-gelatin or carbamide-poly-rafter acid or glyceryl stearate.
Compound method: after getting Fructus Momordicae charantiae extract and be crushed to 80-100 order granularity by prescription, with the substrate mixing, be heated to 80-100 ℃ of said medicine and enter molten condition, stir, adopting craft or machinery that spice is splashed in 15 ℃ of its liquid paraffins through the rustless steel nib under the 60-80 ℃ of keeping warm mode, cooling forming at room temperature, the demoulding promptly gets drop pill after the shaping.
2, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 30 parts of medicine Fructus Momordicae charantiae extracts; 60 parts of substrate.All the other are the same.
3, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 10 parts of medicine Fructus Momordicae charantiae extracts; 30 parts of substrate.All the other are the same.
4, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 1 part of medicine Fructus Momordicae charantiae extract; 20 parts of substrate.All the other are the same.
5, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 1 part of medicine Fructus Momordicae charantiae extract; 80 parts of substrate.All the other are the same.
6, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 40 parts of medicine Fructus Momordicae charantiae extracts; 20 parts of substrate.All the other are the same.
7, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 80 parts of medicine Fructus Momordicae charantiae extracts; 80 parts of substrate.Substrate is mannitol: chitosan: sweeting agent is 1: 0.25: 0.025.
Compound method: after getting Fructus Momordicae charantiae extract and be crushed to 80-100 order granularity by prescription, with substrate mixing, tabletting.
8, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 1 part of medicine Fructus Momordicae charantiae extract; 20 parts of substrate.Substrate is mannitol: chitosan: sweeting agent is 1: 0.125: 0.062.All the other are the same.
9, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 30 parts of medicine Fructus Momordicae charantiae extracts; 20 parts of substrate.Substrate is mannitol: chitosan: sweeting agent is 1: 0.2: 0.02.All the other are the same.
10, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 1 part of medicine Fructus Momordicae charantiae extract; 80 parts of substrate.Substrate is mannitol: chitosan: sweeting agent is 1: 0.1: 0.06.All the other are the same.
11, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes
Prescription (weight portion): 60 parts of medicine Fructus Momordicae charantiae extracts; 80 parts of substrate.Substrate is mannitol: chitosan: sweeting agent is 1: 0.19: 0.04.All the other are the same.

Claims (8)

1, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes is made up of medicine and substrate, it is characterized in that (weight portion):
Medicine is Fructus Momordicae charantiae extract 1-80 part;
Substrate 20-80 part;
By the prescription thing of getting it filled, after the pulverizing,, be processed into dosage form with the substrate mixing.
2, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 1 is characterized in that described dosage form is a drop pill, Fructus Momordicae charantiae extract 1-40 part.
3, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 2 is characterized in that described substrate is Macrogol 4000-6000.
4, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 2 is characterized in that described substrate is sodium stearate.
5, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 2 is characterized in that described substrate is glycerol-gelatin.
6, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 2 is characterized in that described substrate is carbamide-polycitric acid.
7, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 2 is characterized in that described substrate is glyceryl stearate.
8, a kind of Fructus Momordicae charantiae Chinese medicine preparation for the treatment of diabetes according to claim 1 is characterized in that described dosage form is a tablet, and described substrate is: mannitol: chitosan: sweeting agent corresponds to 1: 0.25~and 0.125: 0.025~0.062.
CNA031117678A 2003-01-27 2003-01-27 Diabetes treating bitter gourd traditional Chinese medicine Pending CN1520857A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA031117678A CN1520857A (en) 2003-01-27 2003-01-27 Diabetes treating bitter gourd traditional Chinese medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA031117678A CN1520857A (en) 2003-01-27 2003-01-27 Diabetes treating bitter gourd traditional Chinese medicine

Publications (1)

Publication Number Publication Date
CN1520857A true CN1520857A (en) 2004-08-18

Family

ID=34283504

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA031117678A Pending CN1520857A (en) 2003-01-27 2003-01-27 Diabetes treating bitter gourd traditional Chinese medicine

Country Status (1)

Country Link
CN (1) CN1520857A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102894364A (en) * 2012-10-19 2013-01-30 安徽农业大学 Preparation method of balsam pear/green tea sugar-reducing buccal tablets
CN107307417A (en) * 2017-06-17 2017-11-03 深圳市领治医学科技有限公司 A kind of type 2 diabetes patient's nutriment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102894364A (en) * 2012-10-19 2013-01-30 安徽农业大学 Preparation method of balsam pear/green tea sugar-reducing buccal tablets
CN107307417A (en) * 2017-06-17 2017-11-03 深圳市领治医学科技有限公司 A kind of type 2 diabetes patient's nutriment

Similar Documents

Publication Publication Date Title
CN1709302A (en) Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method
CN101461832A (en) Bioadhesive paster for treating mouth ulcer
CN1520857A (en) Diabetes treating bitter gourd traditional Chinese medicine
CN100342875C (en) Chinese medicinal capsule for treating piles and its preparing process
CN1194724C (en) Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof
CN1202820C (en) Subprostrate sophora oral preparation, preparing method and use
CN1155380C (en) Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis
US10322157B2 (en) Method of treatment of drug-resistance diabetes mellitus
CN1272054C (en) Medicine for treating diabetes and its preparing process
CN1233364C (en) Chinese medicine for treating digestive ulcerating sore and its preparation method
CN103181945B (en) The purposes of Semen Luffae
CN1282479C (en) Slowly-released traditional Chinese medicine adhering tablet for treating mouth mucous diseases and its prepn. method
CN103191170B (en) Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof
CN115919918B (en) Application of luffa alcohol precipitation extract
CN104027450B (en) A kind of Chinese medicine composition for the treatment of diabetes
CN1575803A (en) Application method of Aloe vera L. extract in preventing and curing diabetes
CN107625796A (en) A kind of medical composition and its use containing the root of Dahurain angelica
CN110575447B (en) Pharmaceutical composition for preventing and treating diabetes and application thereof
CN1520858A (en) Diabetes treating thirsty-dispelling drop pills
CN101053598A (en) Medicinal composition for treating cardio-cerebralvascular diseases and diabetes
CN101653489A (en) Application of Chinese medicinal composition in preparation of medicament for preventing diabetes
CN1244324C (en) Reforming effect of arginine to recessive harm of skin tissue of diabetic
CN1520810A (en) Fatty liver therapeutic drug
CN1520815A (en) Flavescent sophora root drop pills for treating hepatitis B
CN100563679C (en) The medicine of treatment hepatitis B great three positive, small three positive hepatopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication